MannKind Corp Files 2024 10-K
Ticker: MNKD · Form: 10-K · Filed: Feb 26, 2025 · CIK: 899460
| Field | Detail |
|---|---|
| Company | Mannkind CORP (MNKD) |
| Form Type | 10-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
MannKind's 2024 10-K is in. Check financials and Cipla deal details.
AI Summary
MannKind Corporation filed its 10-K for the fiscal year ending December 31, 2024, detailing its financial performance and business operations. The company, incorporated in Delaware, is headquartered in Danbury, CT, and operates in the pharmaceutical preparations sector. Key financial data and operational agreements, including those with Cipla Ltd. for licensing and distribution, are outlined in the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of MannKind's financial health, strategic partnerships, and operational status for the past fiscal year, influencing investment decisions.
Risk Assessment
Risk Level: medium — The filing contains standard disclosures for a public company, but the pharmaceutical industry inherently carries risks related to drug development, regulatory approval, and market competition.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
- 133607736 — IRS Number (Company's Employer Identification Number)
- 000-50865 — SEC File Number (Company's SEC registration number)
Key Players & Entities
- MannKind Corp (company) — Filer of the 10-K
- Danbury, CT (location) — Company headquarters
- Cipla Ltd (company) — Partner in licensing and distribution agreement
- 2024-12-31 (date) — Fiscal year end
- 2025-02-26 (date) — Filing date
FAQ
What is the primary business of MannKind Corporation?
MannKind Corporation operates in the Pharmaceutical Preparations sector, as indicated by its SIC code 2834.
When did MannKind Corporation file its 10-K report?
MannKind Corporation filed its 10-K report on February 26, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Where is MannKind Corporation headquartered?
MannKind Corporation is headquartered at 1 Casper Street, Danbury, CT 06810.
Does the filing mention any specific agreements or partnerships?
Yes, the filing references a License and Distribution Agreement with Cipla Ltd, identified as mnkd:CiplaLtdMember.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 regarding MANNKIND CORP (MNKD).